share_log

賽生藥業：根據《收購守則》規則22作出的交易披露

SCICLONE PHARMA: Disclosure of Dealings under Rule 22 of the Takeovers Code

Hong Kong Stock Exchange ·  Apr 30 18:13
Summary by Futu AI
赛生药业控股有限公司於2024年4月30日宣布，公司執行人員Peter Shao Chihwen根據香港《公司收購及合併守則》規則22進行了股份交易。該交易涉及於2024年4月29日按照公司首次公開發售後受限股份單位計劃，將48,750股股份獎勵歸屬於Peter Shao Chihwen，並以每股$0.0000的價格進行買入，交易後Peter Shao Chihwen持有的股份總數達到129,581股，佔公司發行股份的0.0206%。
赛生药业控股有限公司於2024年4月30日宣布，公司執行人員Peter Shao Chihwen根據香港《公司收購及合併守則》規則22進行了股份交易。該交易涉及於2024年4月29日按照公司首次公開發售後受限股份單位計劃，將48,750股股份獎勵歸屬於Peter Shao Chihwen，並以每股$0.0000的價格進行買入，交易後Peter Shao Chihwen持有的股份總數達到129,581股，佔公司發行股份的0.0206%。
Sai Sing Pharmaceutical Holdings Limited announced on 30 April 2024 that its Executive Officer Peter Shao Chihwen has entered into a share transaction pursuant to Rule 22 of the Hong Kong Code of Mergers and Mergers. The transaction involves assigning an award of 48,750 shares to Peter Shao Chihwen under the Company's initial public offering limited share plan on April 29, 2024 and purchased at a price of $0.0000 per share. After the transaction, the total number of shares held by Peter Shao Chihwen reached 129,581 shares of the Company's issued shares. 0.0206% of the portion.
Sai Sing Pharmaceutical Holdings Limited announced on 30 April 2024 that its Executive Officer Peter Shao Chihwen has entered into a share transaction pursuant to Rule 22 of the Hong Kong Code of Mergers and Mergers. The transaction involves assigning an award of 48,750 shares to Peter Shao Chihwen under the Company's initial public offering limited share plan on April 29, 2024 and purchased at a price of $0.0000 per share. After the transaction, the total number of shares held by Peter Shao Chihwen reached 129,581 shares of the Company's issued shares. 0.0206% of the portion.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.